News

CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) ("CMBT", "CMB.TECH" or "the Company") will release its second quarter 2025 earnings prior to market opening on Thursday ...
StandardAero Inc (SARO) reports a 13.5% revenue increase and raises 2025 guidance amid robust demand and strategic ...
Surgepays Inc (SURG) reports a robust revenue increase and strategic alliances, despite facing financial hurdles and market ...
Hyperfine Inc (HYPR) reports a 26% revenue increase and international expansion, despite facing operational costs and net ...
Globally diversified core strategy based on the Global Perspectives unique investment philosophy and built with Voya’s suite ...
Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ETCompany ParticipantsDale Schneider - Chief Financial ...
Net cash used in operating activities (GAAP) was $1,400,000 in fiscal Q2 2025, compared to $3,700,000 provided in fiscal Q2 ...
Record Mill Throughput: In Q2 2025, Avino achieved 36% higher mill throughput versus Q2 2024, totalling a quarterly record of 190,987 tonnes of material. These throughput levels were a result of ...
NORTH BILLERICA, MA / ACCESS Newswire / August 12, 2025 / Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean ...
Chief Financial Officer Barry Berlin reported, "Our FFO was negative $7.9 million or negative $10.42 per diluted share compared to negative $3.3 million or negative $3.46 per diluted share in the ...
The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.
The brokerage believes its Elevate program holds the key to future success after returning to adjusted EBITDA profitability in Q2.